Correction to Novo Nordisk Drug Article
December 23 2014 - 6:22PM
Dow Jones News
The Novo Nordisk AS diabetes drug approved by the FDA is
Liraglutide. "FDA Approves Novo Nordisk Diabetes Drug's Use to
Fight Obesity," at 4:15 p.m. EST, misstated the name of the drug in
the second paragraph.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Novo Nordisk (NYSE:NVO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Novo Nordisk (NYSE:NVO)
Historical Stock Chart
From Apr 2023 to Apr 2024